TY - JOUR
T1 - Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control
AU - Caimmi, D.
AU - Baiz, N.
AU - Tanno, L. K.
AU - Demoly, P.
AU - Arnavielhe, S.
AU - Murray, R.
AU - Bedbrook, A.
AU - Bergmann, K. C.
AU - de Vries, G.
AU - Fokkens, W. J.
AU - Fonseca, J.
AU - Haahtela, T.
AU - Keil, T.
AU - Kuna, P.
AU - Mullol, J.
AU - Papadopoulos, N.
AU - Passalacqua, G.
AU - Samolinski, B.
AU - Tomazic, P. V.
AU - Valiulis, A.
AU - van Eerd, M.
AU - Wickman, M.
AU - Annesi-Maesano, I.
AU - Bousquet, J.
AU - AUTHOR GROUP
AU - Agache, I.
AU - Angles, R.
AU - Anto, J. M.
AU - Asayag, E.
AU - Bacci, E.
AU - Bachert, C.
AU - Baroni, I.
AU - Barreto, B. A.
AU - Bedolla-Barajas, M.
AU - Bertorello, L.
AU - Bewick, M.
AU - Bieber, T.
AU - Birov, S.
AU - Bindslev-Jensen, C.
AU - Blua, A.
AU - Bochenska Marciniak, M.
AU - Bogus-Buczynska, I.
AU - Bosnic-Ancevich, S.
AU - Bosse, I.
AU - Bourret, R.
AU - Bucca, C.
AU - Buonaiuto, R.
AU - Caiazza, D.
AU - Caillot, D.
AU - Caimmi, D. P.
AU - Hellings, P.
PY - 2017
Y1 - 2017
N2 - Background: Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients. Objective: The aim of this study was to validate the use of VAS in the MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) app (Allergy Diary) on smartphones screens to evaluate allergic rhinitis symptoms and disease control. Methods: Each user filled 4 different VAS measuring overall, nasal, ocular, and asthma symptoms at least once. Following COSMIN guidelines, we evaluated internal consistency, (Cronbach's alpha coefficient and test-retest), reliability (intraclass correlation coefficients), sensitivity, and acceptability of the MASK-Rhinitis VAS. Results: Between 1 August 2015 and 31 July 2016, the app was used 14 612 times in 15 countries. A total of 1225 users used it more than once, during the evaluated period. The tool resulted to be statistically satisfactory, showing excellent internal consistency (Cronbach's test > 0.84, test-retest > 0.7), reliability (> 0.9), and acceptability. In addition, the tool had a good sensitivity when users (n = 521) answered the VAS twice in less than 3 hours. Conclusions and Clinical Relevance: The MASK-rhinitis VAS is a reliable and valid tool to assess allergic control on smartphone screens, at the population level
AB - Background: Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients. Objective: The aim of this study was to validate the use of VAS in the MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) app (Allergy Diary) on smartphones screens to evaluate allergic rhinitis symptoms and disease control. Methods: Each user filled 4 different VAS measuring overall, nasal, ocular, and asthma symptoms at least once. Following COSMIN guidelines, we evaluated internal consistency, (Cronbach's alpha coefficient and test-retest), reliability (intraclass correlation coefficients), sensitivity, and acceptability of the MASK-Rhinitis VAS. Results: Between 1 August 2015 and 31 July 2016, the app was used 14 612 times in 15 countries. A total of 1225 users used it more than once, during the evaluated period. The tool resulted to be statistically satisfactory, showing excellent internal consistency (Cronbach's test > 0.84, test-retest > 0.7), reliability (> 0.9), and acceptability. In addition, the tool had a good sensitivity when users (n = 521) answered the VAS twice in less than 3 hours. Conclusions and Clinical Relevance: The MASK-rhinitis VAS is a reliable and valid tool to assess allergic control on smartphone screens, at the population level
U2 - https://doi.org/10.1111/cea.13025
DO - https://doi.org/10.1111/cea.13025
M3 - Article
C2 - 28886234
SN - 0954-7894
VL - 47
SP - 1526
EP - 1533
JO - Clinical and experimental allergy
JF - Clinical and experimental allergy
IS - 12
ER -